Medical management of postoperative recurrence in Crohn's disease

Gastroenterology Clinics of North America

Volumn 33, Issue 2, 2004, Pages 347-360

  Van Assche, Gert ^a   Rutgeerts, Paul ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; CORTICOSTEROID; MERCAPTOPURINE; MESALAZINE; NITROIMIDAZOLE; ORNIDAZOLE; SALAZOSULFAPYRIDINE;

CLINICAL TRIAL; CROHN DISEASE; DISEASE SEVERITY; GASTROINTESTINAL TOXICITY; HUMAN; NAUSEA; PERIPHERAL NEUROPATHY; PHENOTYPE; RECURRENT DISEASE; REVIEW; RISK FACTOR; SIDE EFFECT; SMOKING;

6-MERCAPTOPURINE; AMINOSALICYLIC ACIDS; ANTI-BACTERIAL AGENTS; BUDESONIDE; CROHN DISEASE; DECISION TREES; HUMANS; POSTOPERATIVE PERIOD; RECURRENCE;

EID: 2942590682     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2004.02.012     Document Type: Review

References (46)

1. Sachar DB. The problem of postoperative recurrence of Crohn's disease. Med Clin North Am 1990;71:183-8.
2. Tribl B, Turetschek K, Mostbeck G, Schneider B, Stain C, Potzi R, et al. Conflicting results of ileoscopy and small bowel double-contrast barium examination in patients with Crohn's disease. Endoscopy 1998;30:339-44.
3. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99:956-63.
4. Olaison G, Smedh K, Sjödahl R. Natural course of Crohn's disease after ileocolonic resection: endoscopically visualized ileal ulcers preceding symptoms. Gut 1992;33:331-5.
5. Becker JM. Surgical therapy for ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1999;28:371-90.
6. Chardavoyne R, Flint GW, Pollack S, Wise L. Factors affecting recurrence following resection for Crohn's disease. Dis Colon Rectum 1986;29:495-502.
7. D'Haens GR, Gasparaitis AE, Hanauer SB. Duration of recurrent ileitis after ileocolonic resection correlates with presurgical extent of Crohn's disease. Gut 1995;36:715-7.
8. Rutgeerts P, Geboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991;338:771-4.
9. D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal excluded ileum. Gastroenterology 1998;114:262-7.
10. Viscido A, Corrao G, Taddei G, Caprilli R. Crohn's disease activity index" is inaccurate to detect the postoperative recurrence in Crohn's disease. A GISC study. Gruppo Italiano per lo Studio del Colon e del Retto. Ital J Gastroenterol Hepatol 1999;31:274-9.
11. de Dombal FT, Burton I, Goligher C. The early and late results of surgical treatment for Crohn's disease. Br J Surg 1971;11:805-16.
12. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988;29:588-92.
13. Pallone F, Boirivant M, Stazi MA, et al. Analysis of clinical course of postoperative recurrence in Crohn's disease of distal ileum. Dig Dis Sci 1992;37:215-9.
14. Post S, Herfarth C, Bohm E, et al. The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparatomy for recurrent Crohn's disease. Ann Surg 1996;223:253-60.
15. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994;106:643-8.
16. Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990;98:1123-8.
17. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996;110:424-31.
18. Cosnes J, Beaugerie L, Carbonnel F, Gendre JP. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001;120:1093-9.
19. Lautenbach F, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology 1998;115:259-67.
20. Sachar DB, Wolfson DM, Greenstein AJ, Goldberg J, Styczynski R, Janowitz HD. Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology 1983;85:917-21.
21. Shivananda S, Hordijk ML, Pena AS, Mayberry JF. Crohn's disease: risk of recurrence and reoperation in a defined population. Gut 1989;30:990-5.
22. Caprilli R, Corrao G, Taddei G, Tonelli F, Torchio P, Viscido A. Prognostic factors for postoperative recurrence of Crohn's disease. Dis Colon Rectum 1996;39:335-41.
23. Brignola C, Cottone M, Pera A, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Gastroenterology 1995;108:345-9.
24. Florent CH, Corto A, Quandale P, et al. Placebo-controlled trial of ClaversalR in the prevention of early endoscopic relapse after "curative" resection for Crohn's disease. Gastroenterology 1992;102:A623.
25. Fiasse R, Fontaine F, Vanheuverzwyn R. Prevention of Crohn's disease recurrences after intestinal resection with Eudragit-L-coated 5-aminosalicylic acid: preliminary results of a one-year double-blind placebo controlled study. Gastroenterology 1991;100:A208.
26. Frieri G, Pimpo MT, Andreoli A, Annese V, Comberlato M, Corrao G, et al. Prevention of postoperative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del Retto. Aliment Pharmacol Ther 1999;13:577-82.
27. Caprilli R, Cottone M, Tonelli F, Sturniolo G, Castiglione F, Annese V, et al. Two mesalazine regimens in the prevention of the postoperative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther 2003;17:517-23.
28. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995;108:1617-21.
29. Rutgeerts P, Van Assche G, D'Haens G, et al. Ornidazol for prophylaxis of postoperative Crohn's disease: final results of a double placebo controlled trial. Gastroenterology 2002;122:A80.
30. Adler DJ, Korelitz BI. The long-term efficacy of 6-mercaptopurine in the treatment of inflammatory bowel disease: In: MacDermott RP, editor. Inflammatory bowel disease: current status and future approach. New York: Elsevier Science; 1999. p. 731-5.
31. Bergman L, Krause U. Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin). Scand J Gastroenterol 1976;11:651-6.
32. Wenckert A, Kristensen M, Eklund AE, et al. The long term prophylactic effect of salazosulphapyridine (Salazopyrin) in primary resected patients with Crohn's disease. Scand J Gastroenterol 1978;13:161-7.
33. Ewe K, Herfarth HC, Malchow WH, Jesdinsky HJ. Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulphasalazine prophylaxis. Digestion 1989;42:224-32.
34. Caprilli R, Andreoli A, Capurso L, et al. Oral mesalazine (Asacol) for the prevention of postoperative recurrence of Crohn's disease. Aliment Pharmacol Ther 1994;8:35-43.
35. McLeod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995;109:404-13.
36. Lochs H, Mayer M, Fleig W, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine. European Cooperative Crohn's Disease Study VI. Gastroenterology 2000;118:264-73.
37. Camma C, Giunta M, Roselli M, Cottone M. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology 1997;113:1465-73.
38. Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. Gastroenterology 1999;116:294-300.
39. D'Haens G, Geboes K, Rutgeerts P. Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine. Gastrointest Endosc 1999;50:667-71.
40. D'haens G, Van Deventer S, Van Hogezand R, Chalmers D, Kothe C, Baert F, et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial. Gastroenterology 1999;116:1029-34.
41. Baert FJ, D'Haens GR, Peeters M, Hiele MI, Schaible TF, Shealy D, et al. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 1999;116:22-8.
42. Colombel JF, Rutgeerts P, Malchow H, et al. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut 2001;49:42-6.
43. Campieri M, Rizello F, Venturi A, et al. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of postoperative recurrence of Crohn's disease: a randomized controlled study vs mesalamine. Gastroenterology 2000;118:A781.
44. Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 2002;51:405-9.
45. Brignola C, Cottone M, Pera A, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Gastroenterology 1995;108:345-9.
46. Sutherland LR, Martin F, Bailey RJ, et al. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's Disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology 1997;112:1069-77.